October 15, 2012

The Food and Drug Administration may be willing to speed up trials for drugs that could be a big benefit to society despite their risks.

October 15, 2012

Walmart and Humana have teamed up again to help Medicare beneficiaries afford their prescriptions. With annual enrollment open until Dec. 7, 2012, for 2013 Medicare plans, the Humana-Walmart Preferred Rx Plan announced that it offers one monthly plan premium of $18.50 a month for beneficiaries in all 50 states and Washington, D.C., regardless of where they live.

October 15, 2012

Walgreens will be offering free, personalized Part D plan comparison reports to help beneficiaries identify the plan that best meets their prescription drug needs, the retail pharmacy operator announced Monday.

October 15, 2012

Watson Pharmaceuticals announced that its subsidiary, Watson Laboratories, has received Food and Drug Administration approval on its abbreviated new drug application for irbesartan tablets — the generic equivalent to Sanofi's Avapro — in the 75-mg, 150-mg and 300-mg strengths.

October 12, 2012

Medical supply company BD has introduced a disposable injection pen that it said was designed for drugs requiring frequent, low-volume injections or variable dosing.

October 12, 2012

When given a choice, patients prefer to receive an electronic prescription if they receive a prescription from their physician, according to the most recent Patient Views infographic. To be specific, 64% of respondents said they would choose an e-prescription when provided an option, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. How many patients are actually given a choice as to how they receive their prescription, and how many currently are receiving electronic prescriptions?

October 12, 2012

The Food and Drug Administration has approved an injected drug for lung cancer made by Celgene, the company said Friday.

October 12, 2012

The Food and Drug Administration has approved a new use for a drug made by Roche division Genentech.

October 12, 2012

The Food and Drug Administration has approved a drug made by Sandoz for treating symptoms of various skin diseases.

October 12, 2012

Pharmacy automation manufacturer Kirby Lester has launched a version of one of its tablet counters with streamlined verification software.

October 11, 2012

Frank Scorpiniti, CEO of Rexall Pharma Plus, issued a statement this week applauding the Ontario government’s announcement that it will expand the role of pharmacists to provide more options for Ontarians’ healthcare needs.

October 10, 2012

The Food and Drug Administration has approved a generic drug for treating blood pressure and chest pain.

October 10, 2012

Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said.

October 10, 2012

With the Medicare Annual Election Period set to begin Oct. 15, Walgreens on Wednesday announced it will be a part of preferred pharmacy networks of four national Medicare Part D plan sponsors: Coventry, Humana, SmartD Rx and UnitedHealthcare.

October 9, 2012

According to Surescripts, almost 400,000 physicians — about 58% of all office-based doctors — were e-prescribing at the end of 2011. The net effect: About 36% of all prescriptions were sent electronically in 2011.


October 9, 2012

With healthcare reform on track to bring 32 million more Americans into the healthcare system in 2014, and with payers and patients looking for solutions to curb costs as the nation battles a shortage of primary care physicians and access to quality care, CVS Caremark’s role in reinventing pharmacy through its distinctive business model couldn’t be more imperative than it is today.


October 9, 2012

Specialty may be the fastest-growing segment, but it may also be the most complicated, as this segment is comprised of very complex medications to treat such serious diseases as cancer, multiple sclerosis and hemophilia.

October 9, 2012

CVS Caremark is also working to reinvent the role of its retail pharmacists and is gaining share by focusing on customer service, greater adherence, increased access and patient 
care improvements.

October 5, 2012

The Food and Drug Administration has reviewed new data that indicated that budeprion XL (bupropion hydrochloride extended-release tablets) in the 300-mg strength, manufactured by Impax Labs and Teva Pharmaceuticals USA, is not therapeutically equivalent to Wellbutrin XL in the 300-mg strength.

October 5, 2012

What if Moore's law — meaning the number of transistors per square inch on integrated circuits would double every two years — applied to healthcare applications?

October 5, 2012

In partnership with international regulatory and law enforcement agencies, the Food and Drug Administration on Thursday announced it had taken action against more than 4,100 Internet pharmacies that illegally sell unapproved drugs to consumers.

October 5, 2012

The National Community Pharmacists Association on Thursday commended a bipartisan group of 13 U.S. representatives for a letter they jointly sent to the Drug Enforcement Administration requesting “clarification, guidance and collaboration,” and suggesting that the federal agency’s efforts in addressing supply chain issues of controlled substances across Florida-based distribution centers and pharmacies may be inadvertently preventing patients from accessing certain prescription drugs for which they have legitimate medical needs and prescriptions.

October 4, 2012

“Drugs don’t work in patients who don’t take them.” Sounds simple enough. But that obvious truism, voiced by former U.S. surgeon general C. Everett Koop, fails to convince tens of millions of patients that they should take their prescription medicines through the full dosage regimen.

October 3, 2012

Walgreens on Wednesday posted a 7.8% decline in its September sales to nearly $5.5 billion, compared with $5.9 billion for the same month in fiscal 2012.